➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
AstraZeneca
Moodys
Boehringer Ingelheim
McKinsey

Last Updated: September 19, 2020

DrugPatentWatch Database Preview

Litigation Details for Waymo LLC v. Uber Technologies, Inc. (N.D. Cal. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Waymo LLC v. Uber Technologies, Inc. (N.D. Cal. 2017)

Small Molecule Drugs cited in Waymo LLC v. Uber Technologies, Inc.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .
Biologic Drugs cited in Waymo LLC v. Uber Technologies, Inc.

Details for Waymo LLC v. Uber Technologies, Inc. (N.D. Cal. 2017)

Date Filed Document No. Description Snippet Link To Document
2017-07-27 1035 Opposition/Response to Motion Waymo disclosed: 6 108. 7 8 9 109. 10 11 12 (Dkt. 25-7 at Nos. 108 and 109.) …claims of 9 trade secret misappropriation and patent infringement to pursue at trial. To hold otherwise…12 cv 630 (N.D. Cal 2012) (infringement of four patents alleged on 25 preliminary injunction (‘647, ‘604…but trial alleged infringement of five 26 patents, including two not raised on preliminary injunction…February 2017 3:17-cv-00939-WHA 830 Patent Both District Court, N.D. California External link to document
2017-08-04 1086 Exhibit 8 [REDACTED] 09:35:33 9 MS. RAY: …February 2017 3:17-cv-00939-WHA 830 Patent Both District Court, N.D. California External link to document
2017-08-04 1088 Revised Redacted Version of [1059-6] 10 attorneys? 10:41:44 11 or Uber attempted to learn what the subject…February 2017 3:17-cv-00939-WHA 830 Patent Both District Court, N.D. California External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
McKinsey
McKesson
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.